PROS1 and COVID-19: Different forms of the S protein, including the full-length S protein (either wild-type or a prefusion-stabilized version), RBD, S1 subunit, and S2 subunit are currently used in preclinical and clinical trials of DNA vaccines for COVID-19 (Tables 1 and 2).